Content about Erythropoiesis-stimulating agents

November 29, 2012
NewsBytes — Chain Pharmacy, 12/10/12

Watson Pharmaceuticals is changing its name to Actavis following its acquisition of the Swiss drug maker, Watson said.

October 31, 2012
Sandoz starts phase-3 trial of biosimilar anemia drug

Generic drug maker Sandoz has started a late-stage clinical trial in the United States for a biosimilar treatment for anemia, the company said.

March 28, 2012
FDA approves Omontys for kidney disease-related anemia

The Food and Drug Administration has approved a new treatment for anemia in patients with chronic kidney disease.

January 10, 2012
Hospira enrolls first patient in biosimilar trial

Generic drug maker Hospira has enrolled the first patient in a late-stage clinical trial of a biosimilar drug for treating kidney disease.

September 19, 2011
FDA approves two new indications for Amgen's Prolia

The Food and Drug Administration has approved two new uses for a drug made by Amgen, the drug maker said Monday.

April 1, 2011
Watson receives FDA approval for Nulecit

The Food and Drug Administration has approved a generic treatment for iron deficiency anemia made by Watson Pharmaceuticals, Watson said Thursday.

September 23, 2010
Amgen recalls certain lots of Epogen, Procrit

Several lots of two drugs used to treat anemia are being recalled due to possible...

August 8, 2010
Dr. Reddy's launches Cresp

Generic drug maker Dr. Reddy’s has launched in India the world’s first follow-on version of...

August 4, 2010
Amgen's sales, profits rise in Q2

Biotech company Amgen had $3.8 billion in sales and $1.33 billion in profits during second...

August 2, 2010
Hospira reports Q2 sales, announces clinical trial for biosimilar

Hospira had net sales of $968 million and profits of $83.5 million in second quarter...

January 6, 2010
Report: FDA to investigate safety of anemia drugs

The Food and Drug Administration plans to review three drugs designed to treat anemia, according...

© 2013 Drug Store News. All Rights Reserved.